Acute Exacerbation of Chronic Hepatitis B During Thalidomide Therapy for Multiple Myeloma: A Case Report
Soo Mee Bang, Sun Suk Kim, Se Hoon Park, Jeong Yeal Ahn, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee
Korean J Intern Med. 2004;19(3):196-198. Published online 2004 Sep 1 DOI: https://doi.org/10.3904/kjim.2004.19.3.196
Citations to this article as recorded by 
The interplay between hepatitis B virus and antitumor drugs in the treatment of hepatocellular carcinoma
Tianyu Ma, Feilong Zhao, Linmei Yao, Chuanchun Mao, Yuan Tian, Youyou Ma, Fanyun Kong, Ruyu Liu
Clinical and Experimental Medicine.2025;[Epub] CrossRef
Ubiquitin: A double-edged sword in hepatitis B virus-induced hepatocellular carcinoma
Arpita Kar, Sandipan Mukherjee, Soumyadeep Mukherjee, Avik Biswas
Virology.2024; 599: 110199. CrossRef
Hepatitis B virus infection and 1q21 amplification in multiple myeloma
Dan Guo, Peipei Xu, Chaoyang Guan, Yong Xu, Yonggong Yang, Jingyan Xu, Rongfu Zhou, Bing Chen
Oncology Letters.2019;[Epub] CrossRef
Hepatitis B reactivation after thalidomide
A. P. Grigg, J. Sasadeusz
Internal Medicine Journal.2008; 38(4): 301. CrossRef
Hepatitis B Virus Reactivation in Patients Receiving Chemotherapy for Cancer Treatment: Role of Lamivudine Prophylaxis
Bertrand Coiffier
Cancer Investigation.2006; 24(5): 548. CrossRef